EGFR and central nervous system cancer: Additionally, SOX2 [a pluripotency factor highly expressed in embryonic, neural and glioma stem cells (Suvà et al, 2014)] and c‐Jun [an anti‐apoptotic factor involved in glioma‐genesis (Yoon et al, 2012)] targets correlated to EGFR dose (Fig 5).